glp-1 drugs cancer Dr GLP-1 Drugs Linked to Dramatically

However, it is often prescribed off-label (for a non-FDA-approved use) for weight loss

The drug performed better on all secondary endpoints as well, including a greater percentage of people losing at least 15% of their weight (roughly a third of those on the highest dose achieved this)

These findings should be positioned as hypothesis-generating, and their clinical translatability requires validation in larger samples with pre-specified endpoints (113116)

It was added because rodents developed thyroid C-cell tumors in animal studies, and that raised enough concern to justify a strong warning label

Welcia Japan supported semaglutide distribution under public insurance Walgreens USA reported semaglutide among top-selling diabetes injectables Drogasil Brazil stocked semaglutide across metro-area retail outlets Insured Patients Accounted for 42% of Prescriptions Insured patients represented 42% of ozempic volume in 2025, driven by broad access under national and private reimbursement schemes